Who We Are

CanRIO is a network of Canadian rheumatologists and researchers with expertise in the management of the rheumatic complications of cancer immunotherapy. These include the development of new rheumatic conditions which develop during or after treatment with immunotherapy, termed rheumatic immune related adverse events (Rh ir-AE) and on the management of patients with rheumatic disease who are being treated or being considered for treatment with immunotherapy.

Site content continues to be developed and will be updated on a continuous basis as emerging evidence becomes available.  Please check back frequently!

Read More

Mission Statement

To improve the care of cancer patients across Canada receiving immunotherapy, who develop rheumatic complications or have pre-existing autoimmune conditions, through collaboration, education and research.

News from CanRIO

Upcoming Case Rounds

Case Rounds

Join us for Case Rounds! CanRIO will be hosting a bi-monthly case rounds open to rheumatologists, oncologists, residents or any… Read More

Studies from CanRIO

CanRIO Recommendations for the Assessment and…

Coming 2021! With support from the Canadian Rheumatology Association (CRA) Guidelines Committee, CanRIO has assembled a working group of rheumatologists,… Read More

A Prospective Cohort Study of Adults with…

Currently recruiting! This is an ongoing prospective, multi-centre, Canadian study looking at clinical phenotypes, outcomes and biomarker profiles of adults… Read More

General Updates

Welcome to

CanRIO is thrilled to launch the first educational website dedicated to the rheumatic complications of immunotherapy. We hope that this… Read More

Hot off the Press!

CanRIO has just published its second national case series. This retrospective cohort study included 27 patients with pre-existing autoimmune disease… Read More